2Cosmi L, Annunziato F, Galli MIG, et al. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease[ J]. Eur J Immunol,2000,30(10) :2972.
3张之献.血液病诊断及疗效标准[M].第2版.北京:北京科学出版社,1998.
4Dianzani U, Bragardo M, Difranco D, et al. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymph proliferation [J]. Blood, 1997,89 (8) :2871.
5Yoshimura C, Nomura S, Nagaham M, et al. Plasma-soluble Fas(Apo-1 ,CD95) and soluble Fas ligand in immune thrombocytopenic purpura [ J ]. Eur J Haematol, 2000,64 (4) :219.
6Woodland DL, Dutton RW. Heterogeneity of CD4 ( + ) and CD8( + ) T cells[J]. Curr Opin Immunol,2003,15 (3) :336.
7Mosmann TR, Sad S. The expanding universe of T-cell subsets : Th1, Th2 and more [ J ]. Immunol Today, 1996,17 (3) :138.
8Tsuda H, Michimata T, Sakai M, et al. A novel surface molecule of Th2- and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4^+ and CD8^+ T cells during the early stage of pregnancy [ J ]. Clin Exp Immunol,2001,123( 1 ) :105.
9COSMI L, ANNUNZIATO F, GALLI M I G, et al. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease[J]. Eur J Immunol, 2000, 30:2972-2979.
10YOSHIMURA C, NOMURA S, NAGAHAM M, et al. Plasma-soluble Fas (Apo-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura[J]. Eur J Haematol, 2000, 64:219-224.
